1292279-02-7

Basic information

• Product Name: 2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decane-1,8-dione
• Synonyms: 2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decane-1,8-dione
• CAS NO: 1292279-02-7
• Molecular Weight: 301.386
• Mol File: 1292279-02-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decane-1,8-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decane-1,8-dione(1292279-02-7)
• EPA Substance Registry System: 2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decane-1,8-dione(1292279-02-7)

Safety Data

• Hazardous Substances Data: 1292279-02-7(Hazardous Substances Data)

Upstream product

• 1292279-01-6 8-hydroxy-2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decan-1-one 
• 1292278-43-3 1-(2-methoxy-ethyl)-4-oxo-cyclohexanecarboxylic acid ethyl ester 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 
• 1489-97-0 ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate 
• 7664-66-6 4-(isopropoxy)aniline 

Downstream Products

• 1292276-67-5 (5α,8α)-8-(5-bromo-3-methyl-3H-[1,2,3]triazol-4-yl)-8-hydroxy-2-(4-isopropoxy-phenyl)-2-aza-spiro[4.5]decan-1-one 
• 1292276-77-7 (5α,8α)-8-hydroxy-2-(4-isopropoxyphenyl)-8-(1-methyl-4-vinyl-1H-1,2,3-triazol-5-yl)-2-aza-spiro[4.5]decan-1-one 
• 1401238-11-6 (5α,8α)-8-hydroxy-2-(4-isopropoxy-phenyl)-8-(5-oxo-4-aza-spiro[2.4]hept-4-ylmethyl)-2-aza-spiro[4.5]decan-1-one 

Relevant articles and documents

AZASPIRODECANONE COMPOUNDS

The invention provides novel compounds having the general formula (I) wherein R1 and R2 are as described herein, compositions including the compounds, their pharmaceutically acceptable salts and esters and methods of using the compounds.

NEW AZASPIRODECANONE COMPOUNDS

The invention provides novel compounds having the general formula (I) wherein R1 and R2 are as described herein, compositions including the compounds, their pharmaceutically acceptable salts and esters and methods of using the compou

SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES

Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions as HSL inhibitors for the treatment of diabetes, wherein R1,R2, R3, Ca and Cb have the significance given in claim 1.